Managing the Elderly AML Patient: Clinical Issues and Strategies for Nurses

The incidence of acute myeloid leukemia (AML) is expected to increase as a result of several factors, including the aging of the population, a rise in secondary cases from environmental exposures, and wider recognition that low blood counts may be indicative of a bone marrow disorder rather than a normal consequence of aging. Lower survival rates in older patients with AML may be due to age, disease-related changes, aggressive chemotherapy, or treatment-associated adverse reactions.

The demographic shift occurring in the US during the next two decades underscores a critical need for continuing education for oncology nurses who will have an expanding role in the multidisciplinary management of older cancer patients. The complexity of caring for older adults with AML may place pressures upon the knowledge, competence, and performance of oncology practices. Oncology nurses and nurse practitioners must be able to think critically, analyze, reflect, problem-solve, and apply high-level knowledge that is evidence- and research-based to clinical interactions with patients who need their care.

Learning Objectives

As a result of participating in the activity, learners should be better able to:
- Identify variables that influence AML prognosis and AML treatment in elderly patients
- Evaluate cognitive and physical functioning in elderly patients with AML
- Describe common treatment-related side effects and strategies for side effect management, including those associated with novel and emerging treatment options for AML
- Identify information and support resources for patients with AML and their caregivers